Cargando…

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer

Background: Stereotactic body radiotherapy (SBRT) in ultra-central (UC) lung tumors, defined in the presence of planning target volume (PTV) overlap or direct tumor abutment to the central bronchial tree or esophagus, may be correlated to a higher incidence of severe adverse events. Outcome and toxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loi, Mauro, Franceschini, Davide, Dominici, Luca, Franzese, Ciro, Chiola, Ilaria, Comito, Tiziana, Marzo, Marco, Reggiori, Giacomo, Mancosu, Pietro, Tomatis, Stefano, Nuyttens, Joost, Scorsetti, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226119/ https://www.ncbi.nlm.nih.gov/pubmed/32260568 http://dx.doi.org/10.3390/cancers12040885

Ejemplares similares

Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial
por: Franceschini, Davide, et al.
Publicado: (2022)

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020)

Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma
por: Cozzi, Luca, et al.
Publicado: (2019)

Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
por: Franzese, Ciro, et al.
Publicado: (2023)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

RapidPlan head and neck model: the objectives and possible clinical benefit
por: Fogliata, A., et al.
Publicado: (2017)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
por: Comito, Tiziana, et al.
Publicado: (2023)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection
por: Navarria, Pierina, et al.
Publicado: (2016)

Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy
por: Massaro, Maria, et al.
Publicado: (2022)

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
por: Salvestrini, Viola, et al.
Publicado: (2022)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013)

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy
por: Cozzi, Luca, et al.
Publicado: (2017)

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients
por: Alongi, Filippo, et al.
Publicado: (2012)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy
por: Franzese, Ciro, et al.
Publicado: (2015)

RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies
por: Fogliata, A., et al.
Publicado: (2019)

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy
por: Tozzi, Angelo, et al.
Publicado: (2014)

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study
por: Alongi, Filippo, et al.
Publicado: (2013)

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
por: Comito, Tiziana, et al.
Publicado: (2022)

Twenty Years of Advancements in a Radiotherapy Facility: Clinical Protocols, Technology, and Management
por: Tomatis, Stefano, et al.
Publicado: (2023)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform
por: Scorsetti, Marta, et al.
Publicado: (2023)

MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO)
por: Paganini, Lucia, et al.
Publicado: (2019)

Enhancing Radiotherapy Workflow for Head and Neck Cancer with Artificial Intelligence: A Systematic Review
por: Franzese, Ciro, et al.
Publicado: (2023)

Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors
por: Fogliata, Antonella, et al.
Publicado: (2022)

Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate
por: Cozzi, Luca, et al.
Publicado: (2018)

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
por: Navarria, Pierina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_enkkcocn9giqq4iit7rg2skt9c